← All candidates
104 insider filings on record.
104 filings on record.
FLGTFulgent Genetics, Inc.
NasdaqGM · Healthcare · $582.22M
$21.28
+3.05% · Sep 15
104 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 14 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$582.22M
Float
16.7M
61% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
1.8
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
99 more transactions on Pro →Context
Wall St
$18.50 avg target
-13.1% vs today · 2 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
3 of 4 quarters beat
Q1 '26−$0.36 act−$0.01
Q4 '25$0.16 act+$0.13
Q3 '25$0.14 act+$0.36
Q2 '25$0.07 act+$0.25
Coverage
Fulgent Genetics Inc (FLGT) Q1 2026 Earnings Call Highlights: Navigating Challenges with ...GuruFocus.com · 05-02Fulgent Genetics, Inc. Q1 2026 Earnings Call SummaryMoby · 05-01Fulgent Genetics Q1 Earnings Call HighlightsMarketBeat · 05-01Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Beats Revenue EstimatesZacks · 05-01
The file stays open
104 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice